Zepbound 5MG/0.5ML 4S
Ended Awarded
- Contract number
- SPE2DR26FAQYY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,217
Award facts
- Contract value 100% obligated
- $26,217.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Zepbound 5mg/0.5ml (tirzepatide), a GLP-1 receptor agonist used for weight management and diabetes treatment. The contract, valued at $26,217.23, represents a firm fixed-price delivery order with an ultimate completion date of November 24, 2025. This award operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania.
This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen supplies a broad range of medications and medical supplies to the Defense Health Agency and other federal healthcare entities. The firm fixed-price delivery mechanism allows the DLA to procure critical pharmaceutical products efficiently through its established pharmaceutical prime vendor agreement while maintaining cost certainty and supporting military medical operations.
Quick answers
Who was awarded contract SPE2DR26FAQYY?
SPE2DR26FAQYY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DR26FAQYY worth?
The government has obligated $26,217 on SPE2DR26FAQYY.
Is contract SPE2DR26FAQYY an order under another contract?
Yes. SPE2DR26FAQYY is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAQYY competed?
The extent of competition for SPE2DR26FAQYY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award